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Abstract 
Rivulgo, V.M.; Ceci, M.; Haeublin, G.; Sparo, M.; Sanchez Bruni, S.: Efficacy of the 
probiotic strain Enterococcus faecalis CECT7121 in diarrhea prevention in newborn foals. 
Rev. vet. 27: 1, 3-6, 2016. The aim of this work was to assess the effectiveness of the probiotic 
strain Enterococcus faecalis CECT7121 for the prevention of neonatal diarrhea in one to three 
day-old foals. Fecal samples from twenty foals divided randomly in experimental and control 
groups were studied. The experimental group (n=10) received E. faecalis CECT7121 (1 x 1010 
CFU/ml) orally in the first day of life and for a 6 days period. The control group (n=10) re-
ceived distilled water for the same period. In 4/10 of the foals from the control group diarrhea 
was observed, conversely diarrhea cases were not observed in any of the foals belonging to the 
experimental group. The differences between groups were statistically significant (p<0.001). 
E. faecalis CECT7121 was isolated in faeces from the second day of treatment until six days 
after the end of the probiotic administration. Therefore, E. faecalis CECT 7121 may be con-
sidered as a biological tool for the prevention of neonatal diarrhea in foals. Any adverse effects, 
at least under the conditions of this assay, but more efficacy studies should be performed to 
evaluate this organism in the prevention or treatment of diseases in foals. 
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Resumen
Rivulgo, V.M.; Ceci, M.; Haeublin, G.; Sparo, M.; Sanchez Bruni, S.: Eficacia del probió-
tico Enterococcus faecalis CECT7121 en la prevención de diarreas neonatales en potrillos 
recién nacidos. Rev. vet. 27: 1, 3-6, 2016. El objetivo de este trabajo fue evaluar la eficacia del 
probiótico Enterococcus faecalis CECT7121 en la prevención de la diarrea neonatal en potri-
llos de uno a tres días de edad. Se estudiaron muestras de materia fecal de veinte potrillos di-
vididas al azar en grupos experimental y control. Los animales del grupo experimental (n=10) 
recibieron E. faecalis CECT7121 (1 x 1010 UFC/ml) por vía oral en el primer día de vida y por 
un período de 6 días. El grupo control (n=10) recibió agua destilada por el mismo período. Se 
observó que el 40% de los potrillos del grupo control presentaron diarrea, mientras que no se 
observaron casos de diarrea en ninguno de los potrillos pertenecientes al grupo experimental. 
Las diferencias entre los grupos fueron estadísticamente significativas (p<0,001). E. faecalis 
CECT7121 se aisló en heces desde el segundo día de tratamiento hasta seis días después del 
final de la administración del probiótico. Por lo tanto este hallazgo indicaría que E. faecalis 
CECT7121 podría ser considerado como una herramienta biológica para la prevención de la 
diarrea neonatal en potrillos sin ningún efecto adverso, al menos bajo las condiciones del 
presente ensayo, aunque más estudios de eficacia se deberían realizar para evaluar este orga-
nismo en la prevención o el tratamiento de enfermedades de los potrillos en los haras.
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INTRODUCTION
The occurrence of certain infectious diseases in 
newborn foals such as neonatal diarrhoea can lead to 
great economical losses because of the high cost of 
treatment or the death of foals with systemic sepsis 5, 9, 
10-12 . However, the current antimicrobial treatment for 
diarrhoea control presents high failure rates due to the 
use of broad-range antimicrobials. Hence, the follow-
ing selection of multiresistant bacteria besides the bac-
terial bidirectional transfer between human and animal 
is causing serious therapeutic concerns in clinical prac-Recibido: 28 setiembre 2015 / Aceptado: 3 diciembre 2015 
4tice 2 . In order to prevent the above-mentioned situa-
tion new therapeutic strategies have been investigated 
like the biological control through the use of probiotic 
bacterial strains 13 . 
Probiotics are traditionally defined as viable but 
non-pathogenic microorganisms that when ingested, 
have beneficial effects in the prevention and treatment 
of several enteric diseases 9 . Enterococcus faecalis 
CECT7121, recovered from natural corn silage, is con-
sidered a probiotic strain because of its viability in the 
gastrointestinal tract, gastric pH tolerance, bile salts 
tolerance, intestinal epithelium adhesion capability, 
harmless behaviour, antimicrobial compounds produc-
tion (peptide AP-CECT7121) as well as the specific and 
non-specific immune response triggering. 
Due to these properties E. faecalis CECT7121 
could be an alternative and a new strategy for the pre-
vention of diarrhoea in newborn foals. The aim of this 
study was to assess the efficacy of the probiotic strain E. 
faecalis CECT7121 for the prevention of neonatal diar-
rhoea in newborn foals. 
 MATERIAL AND METHODS
Experimental design. Twenty newborns foals with 
25-50 kg weight were selected to this study from a thor-
oughbred horse stud farm set up in the Province of La 
Pampa (Argentina), in which previous cases of neonatal 
diarrhoea were documented. The foals were kept with 
their dams in individual stalls during the experiment 
with ad libitum access to grass hay and water. The foals 
were randomly divided in, the experimental group (n= 
10) that received E. faecalis CECT7121 (1 x 1010 CFU/
ml) orally in the first day of life and every 24 h along a 6 
days period, and the control group (n= 10) that received 
distilled water (placebo) under the same conditions and 
time period than the experimental group. Diarrhoea 
was defined as the presence of faeces with abnormally 
liquid consistency on more than one occasion in 24 h. 
Foals were checked by the veterinarian daily for signs 
of diarrhoea, the presence of watery faeces, smearing 
of faeces and loss of the hair in the perianal area. The 
faecal samples were collected from the rectum of the 
foals with sterile gloves from the birth and every 24 h 
until the sixth day of life and then, every 48-72 h until 
the twelfth day of life. The diarrhoea was characterized 
by the veterinarian of the stud farm with a score of 1 = 
mild, 2 = moderate, 3 = liquid diarrhoea, the veterinar-
ian don’t know which foals treated with probiotics and 
which with placebo (blinded study).
E. faecalis CECT7121 preparation for experimen-
tal group treatment. An aliquot (200 ul) of defrosted E. 
faecalis was inoculated in 3 ml of brain-heart infusion 
(BHI) broth and incubated at 35°C for 24 h. A new in-
oculation was performed and incubated at 35°C for 24 h.
Visual, physico-chemical and microbiological 
analysis of fecal samples. A) Visual analysis of the fresh 
sample: direct observation was performed to recognize 
any of parasitic forms following the method described 
by 3 . B) Physico-chemical analysis: pH, presence of 
blood and glucose were evaluated. Measurements were 
made using semi-quantitative test strips (Siemens Med-
ical Solution Diagnostics). C) Bacteriological analysis 
of intestinal indigenous microbiota and the presence of 
E. faecalis: for arerobic bacterial cultures, suspensions 
of faecal sample in sterile distilled water with an equiv-
alent density to the 0.5 point of McFarland scale were 
prepared. Each one of these suspensions was inoculated 
on enrichment media using blood agar for 24 h at 35oC, 
and then inoculated in different selective media, using 
conventional biochemical methods according to stan-
dard microbiological techniques 8, 11 . D) Determination 
of resistance to antimicrobial agents was determined 
using disk diffusion method. The following antimicro-
bial agents were used: gentamicin, fluorquinolones, fos-
fomycin, streptomycin and beta-lactamases according 
to CLSI 1 . 
Statistical Analysis. Statistical analysis (Fischer 
exact test) was performed using the program SPSS, 
version 6.0 for comparing the clinical cure of the foals 
involved in this trial.
RESULTS
Clinical results. After administration of the pro-
biotic no signs and symptoms that reflect changes in 
the health status of the foals were observed. In the con-
trol group (placebo) 4/10 of the foals showed mild to 
moderate diarrhoea (score between 1-2 grade). There 
was no record of neonatal septicaemia or death in these 
foals before conventional antimicrobial treatment es-
tablished (streptomycin and activated charcoal). In 
contrast, in the experimental group diarrhoea was not 
observed in any of foals. The Fisher exact test results 
showed that the differences among the groups were sig-
nificant (p<0,001).
Physical-chemical and microbiological analy-
ses of faecal samples. Inoculum control count in the 
order of the administered bacterial concentration (1 
x1010 UFC / ml) was obtained. In the physico-chemical 
analysis there were no glucose and blood detected, the 
change in pH was 5 to 6.3. The experimental and con-
trol group were negative for parasitic and the bacterial 
species isolated in both groups were: Escherichia coli, 
Streptococcus spp and Staphylococcus spp. In 100% 
of the experimental group, E. faecalis CECT7121 was 
isolated from the second day of treatment until six days 
after the end of the probiotic administration (Figures 
1 and 2). In fours foals with diarrhoea (control group) 
the only bacteria isolated was Klebsiella pneumoniae. 
The susceptibility test to the antimicrobial agents used, 
detected multi- resistance of the strain isolated. The 
screening test confirmed the presence of the ESBLs-
producer.
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5DISCUSSION
Despite of the large use of probiotic strains in hu-
man and veterinary medicine there are few published 
works about the application and efficacy of these prod-
ucts in foals. In our study the administration of the pro-
biotic strain E. faecalis CECT7121 for a 6-day period 
was effective for mild to moderate neonatal diarrhoea 
prevention. One of the best-studied probiotics in hu-
man medicine is Lactobacillus rhamnosus strain GG, 
which has been able to survive the gastric acid and bile 
digestion in order to colonize the gastrointestinal tracts 
of humans 4 . 
However in one study employing Lactobacillus 
pentosus WE7 as a probiotic for neonatal diarrhoea pre-
vention reported an increase in the number of diarrhoea 
cases together with the appearance of 
clinical abnormalities 14 . However, in this 
study after given E. faecalis CECT7121 
by 6 consecutive days no adverse effects 
were observed in any of the treated foals 
and our results indicated that E. faecalis 
CECT7121 was isolated from the second 
day of treatment until six days after the 
end of the probiotic administration. And 
the latter will represent a passive bacte-
rial movement through the intestinal tract, 
although not its colonization. 
The results of our isolates of intestinal 
indigenous microbiota of the foals with-
out diarrhoea were consistent with other 
reports 5, 6, 7, 10 . The difference in bacte-
rial isolates between the different studies 
could be because of geographic differenc-
es, temporal differences or also due to a 
compromised gastrointestinal tract lead-
ing to overgrowth of certain bacteria with 
subsequent translocation of these bacteria, 
also the management and stressful envi-
ronmental conditions 15 .
Interestingly, the high resistance to 
gentamicin and the sensitivity to strep-
tomycin based on the antibiogram of the 
Klebsiella pneumoniae ESBL-producer 
make us suspect that this strain would 
come from a human source. This could 
explain the fact that some antimicrobial 
agents (such as streptomycin) is not used 
in human medicine while it is widely used 
in veterinary medicine combined with 
penicillin for treating horses and because 
for the fact that the development of resis-
tance to streptomycin is documented in 
foals. Monitoring the development of an-
timicrobial resistance is pivotal for the ra-
tional selection of appropriate antimicro-
bial drugs to initiate treatment of foals 3 .
In conclusion this work shows that 
the probiotic strain E. faecalis CECT 7121 
can be considered as a biologic tool for the prevention 
of neonatal diarrhoea in foals without any adverse ef-
fects, but more efficacy studies should be performed to 
evaluate this organism in the prevention or treatment of 
diseases in foals in other farms.
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